Candida infection in HIV positive patients 1985-2007

Mycoses

Volumn 51, Issue SUPPL. 2, 2008, Pages 58-61

  Traeder, Christian ^a   Kowoll, Susann ^a   Arastéh, Keikawus ^a  

^a Vivantes Auguste Viktoria Klinikum   (Germany)

Author keywords

Candida esophagitis; Candida non albicans species; Incidence of Candida esophagitis; Opportunistic infections in AIDS

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; POSACONAZOLE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ESOPHAGUS CANDIDIASIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; KAPOSI SARCOMA; KIDNEY FAILURE; MALE; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TOXOPLASMOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDIASIS; CANDIDIASIS, ORAL; COHORT STUDIES; ESOPHAGITIS; HUMANS; MALE;

CANDIDA;

EID: 47949096763     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01574.x     Document Type: Article

References (8)

1. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst Rev 2006 3 : CD003940.
2. Mocroft A, Oancea C, van Lunzen J et al., EuroSIDA study group Decline in esophageal candidiasis and use of antimycotics in European patients with HIV. Am J Gastroenterol 2005 100 : 1446 54.
3. Seage GR III, Losina E, Goldie SJ, Paltiel AD, Kimmel AD, Freedberg KA. The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality. J Acquir Immune Defic Syndr 2002 30 : 421 8.
4. Shen YZ, Qi TK, Ma JX et al. Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital. Mycoses 2007 50 : 475 80.
5. Koks CH, Meenhorst PL, Bult A, Beijnen JH. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons. Pharmacol Res 2002 46 : 195 200.
6. Smith D, Midgley J, Gazzard B. A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection. Int J Clin Pract 1999 53 : 349 52.
7. Sobel JD, Ohmit SE, Schuman P et al., Epidemiology Research Study (HERS) Group The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2001 183 : 286 93.
8. Skiest DJ, Vazquez JA, Anstead GM et al. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. Clin Infect Dis 2007 44 : 607 14.